Tag Archives: Bloomberg

McConnell changes tune on healthcare bill, hints at need for Dems’ input; share the pain maneuver?

The News: Some political policy wonks believe Senate Majority Leader Mitch McConnell is taking a risk by calling for a bipartisan healthcare plan if the Republican-only bill fails. While his… Read more »

Trump’s rejoinder to Senate GOP: repeal Obamacare now, replace it later; or just forget the whole thing.

The News: US President Donald Trump urged Republican senators on Friday (June 30, 2017) to repeal Obamacare immediately if they cannot agree on a new healthcare plan to replace it,… Read more »

GOP Senate bill ignites massive rally in healthcare stocks; remember the dot-com era?

US healthcare stocks posted sharp gains last week, with pharma, hospitals and insurers climbing after Senate Republicans released a draft bill to scrap Obamacare, while a recent explosion in biotech… Read more »

GOP Senate health bill finally unveiled; Republicans now can say at least they tried to scrap Obamacare.

A lot of Americans, including all but literally a handful of our elected representatives, have been sitting on pins and needles, waiting for the Senate to divulge its version of… Read more »

CAR-T Therapy: Personalized medicine with the promise of a cure; payers will decide who gets it

The News: Swiss drug giant Novartis AG has drawn widespread praise and a rising dose of controversy pertaining to its breakthrough CAR-T therapy CTL019. The medicine is under review to… Read more »

Tesaro says it’s for sale, but who can afford it

The News: Just ahead of the year’s biggest download of cancer data, the maker of a closely watched drug has put itself up for sale, according to The Wall Street… Read more »

Universal health care: a “right” or “privilege.” Wrong question, or already settled?

Steve’s Take: Bloomberg’s Ramesh Ponnuru poses the question: “Is there a ‘right’ to healthcare? Our arguments about health policy frequently highlight the question.” He goes on to say that “as… Read more »

Amgen’s osteoporosis med almost a home run in latest trial; fate now murky on heart safety

The News: Amgen Inc. (Thousand Oaks CA) and UCB SA (Brussels) no longer expect their experimental osteoporosis drug to win US approval this year after a higher rate of serious… Read more »

Surprise! GOP health bill never left the House

The News: The US House of Representatives will send its healthcare overhaul plan passed earlier this month to the Senate in a couple of weeks after it receives a final… Read more »

Merck’s Keytruda gets chemo-combo approval for lung cancer; science, stars align for multi-billion medicine

The News: Merck & Co. announced Wednesday (May 10, 2017) that the FDA awarded accelerated approval to Keytruda (pembrolizumab), in combination with Eli Lilly & Co.’s chemotherapy regimen Alimta (pemetrexed)… Read more »